Radiolabeled single-domain antibodies as a means to evoke and monitor immunological responses in malignant lesions

Medicine & Life Sciences

• Single-Domain Antibodies 100%
• Radioisotopes 55%
• Ligands 18%
• Therapeutics 11%
• Neoplasms 10%
• Antigens 8%
• Melanoma 8%
• Macrophages 6%
• Myeloid Cells 6%
• Actinium-225 6%
• Lutetium-177 5%
• Vaccination 5%
• CD20 Antigens 5%
• Technetium 3%
• Nuclear Medicine 3%
• Th1 Cells 3%
• Ovalbumin 3%
• Radionuclide Imaging 3%
• Chickens 3%
• Dendritic Cells 2%
• Interleukin-10 2%
• Immunosuppressive Agents 2%
• Therapeutic Uses 2%
• Flow Cytometry 2%
• Pharmacokinetics 2%
• Vaccines 2%
• Monoclonal Antibodies 2%
• Animal Models 2%
• Clinical Trials 2%
• Cytokines 1%
• Messenger RNA 1%
• Kidney 1%
• Lung 1%
• Liver 1%
• Growth 1%
• Serum 1%
• Population 1%